Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-12-13

Clinical Trial Update: Thiazolidinedione Intervention With Vitamin D Evaluation [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating a thiazolidinedione with vitamin D for type 2 diabetes was terminated, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rosiglitazone (rosiglitazone)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: TERMINATED | Results posted: 2011-12-13